Skip to main content

Articles

Practice Management
Global Issues Driving US Healthcare Trends in 2021 and 2022
F. Randy Vogenberg, PhD; John Santilli, MBA
Read More
Perspectives
Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening
James L. Mulshine, MD; David F. Yankelevitz, MD; Bruce Pyenson, FSA, MAAA
Read More
Perspectives
Thinking About 2030
David B. Nash, MD, MBA
Read More
Original Research, Pain
Insights from Real-World Analysis of Treatment Patterns in Patients with Newly Diagnosed Knee Osteoarthritis
Stan Dysart, MD, MBA; Karina Utkina, PharmD; Laura Stong, PhD; Winnie Nelson, PharmD, MS, MBA; Naomi Sacks, PhD; Bridget Healey, MPH; Faizan Niazi, PharmD
Read More
Original Research, Cardiometabolic Health
Clinical Pharmacist Outreach to Increase Statin Use for Patients with Cardiovascular Disease in a Safety-Net Healthcare System
Paul Cornelison, PharmD; Joel C. Marrs, PharmD, MPH; Sarah L. Anderson, PharmD
Read More
Original Research, Practice Management
Real-World Cost of Care for Commercially Insured versus Medicare Patients with Metastatic Pancreatic Cancer Who Received Guideline-Recommended Therapies
Samantha Tomicki, MPH; Gabriela Dieguez, FSA, MAAA; Helen Latimer, MPH; Paul Cockrum, PharmD; George Kim, MD
Read More
FDA Approvals
Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker
Read More
FDA Approvals
Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations
Read More
FDA Approvals
Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation
Read More
FDA Approvals
Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma
Read More
Page 22 of 244
Results 211 - 220 of 2434